Cleared Traditional

K970230 - SPOROX

K970230 is an FDA 510(k) clearance for SPOROX, manufactured by Reckitt Benckiser, Inc.. The device is a Class 2 General Hospital device with product code MED cleared through the Traditional 510(k) pathway after a 281-day FDA review.

K970230 · Reckitt Benckiser, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1997
Decision
281d
Days
Class 2
Risk

K970230 is an FDA 510(k) clearance for the SPOROX. Classified as Sterilant, Medical Devices (product code MED), Class II - Special Controls.

Submitted by Reckitt Benckiser, Inc. (Montvale, US). The FDA issued a Cleared decision on October 29, 1997 after a review of 281 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.6885 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Reckitt Benckiser, Inc. devices

FDA 510(k) Submission Details - K970230

510(k) Number K970230 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 21, 1997
Decision Date October 29, 1997
Days to Decision 281 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
152d slower than avg
Panel avg: 129d · This submission: 281d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MED Device Classification - Class 2, Special Controls

Product Code MED Sterilant, Medical Devices
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.6885
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - MED Sterilant, Medical Devices

All 34
Devices cleared under the same product code (MED) and FDA review panel - the closest regulatory comparables to K970230.
CIDEX OPA SOLUTION
K991487 · Advanced Sterilization Products · Oct 1999
ENDO-SPOR PLUS / HYPROCIDE
K972708 · Cottrell, Ltd. · Sep 1999
VAPOCIDE
K970726 · Cottrell, Ltd. · May 1998
PERACT 20 LIQUID STERILANT
K960513 · Minntech Corp. · Oct 1997
WAVICIDE MONITOR STRIPS
K932047 · Serim Research Corp. · Jun 1994
CIDEX FORMULA 7* LONG-LIFE ACTIVATED DIALDEHYDE
K924334 · Johnson & Johnson Medical, Inc. · Mar 1994